GlassScriptPhysician profile
Axel Anderson
NPI 1972659225
$8,160.64
in general payments reported to CMS, 2019-2025
32 companies · $1,835 in 2025
The $1,835 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $589 · 2021: $841 · 2022: $1,255 · 2023: $1,246 · 2024: $1,763 · 2025: $1,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,955 · Travel and Lodging: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,954.97 |
| Travel and Lodging | $1,888.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $4,024.70 | 2021-2025 | Urolift, Barrigel |
| Janssen Biotech, INC. | $649.10 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $643.78 | 2019-2025 | Xtandi |
| Coloplast Corp | $442.16 | 2020-2025 | Speedicath |
| Medtronic, INC. | $363.71 | 2022-2024 | Interstim |
| Medtronic USA, INC. | $287.52 | 2019-2020 | |
| Axonics, INC. | $220.66 | 2021-2022 | |
| Antares Pharma, INC. | $191.73 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Neotract INC. | $183.66 | 2020 | |
| Pfizer INC. | $166.94 | 2021-2025 | |
| Clarus Therapeutics INC. | $154.84 | 2021 | |
| Baxter Healthcare | $123.00 | 2023 | Floseal |
| Sumitomo Pharma America, INC. | $115.14 | 2023-2025 | Gemtesa, Orgovyx |
| Myriad Genetic Laboratories, INC. | $112.51 | 2021-2022 | |
| Karl Storz Endoscopy-America | $67.93 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $48.74 | 2022 | |
| Laborie Medical Technologies Corp. | $35.72 | 2023 | |
| Dentsply Ih INC. | $35.53 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $29.16 | 2021 | |
| Abc Home Medical Supply, INC. | $28.68 | 2024 | |
| Smith+Nephew, INC. | $26.13 | 2022 | |
| Acerus Pharmaceuticals Corporation | $25.95 | 2021-2022 | |
| Olympus America INC. | $23.28 | 2023 | Itind System |
| Tolmar, INC. | $23.19 | 2023 | |
| Myovant Sciences INC. | $21.18 | 2022 | |
| Endo Pharmaceuticals INC. | $19.57 | 2021 | |
| 180 Medical, INC. | $19.05 | 2019 | |
| Abbvie INC. | $17.19 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.69 | 2021 | |
| Accord Healthcare, INC. | $15.78 | 2022 | |
| Halozyme INC | $14.40 | 2023 | |
| Boston Scientific Corporation | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Axel Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.